MK-2206 Alleviates Renal Fibrosis by Suppressing the Akt/mTOR Signaling Pathway In Vivo and In Vitro

MLA

Meiling Chen, et al. “MK-2206 Alleviates Renal Fibrosis by Suppressing the Akt/MTOR Signaling Pathway In Vivo and In Vitro.” Cells, vol. 11, no. 21, Nov. 2022, p. 3505. EBSCOhost, https://doi.org/10.3390/cells11213505.

APA

Meiling Chen, Yihang Yu, Tao Mi, Qitong Guo, Bin Xiang, Xiaomao Tian, Liming Jin, Chunlan Long, Lianju Shen, Xing Liu, Jianbo Pan, Yuanyuan Zhang, Tao Xu, Deying Zhang, & Guanghui Wei. (2022). MK-2206 Alleviates Renal Fibrosis by Suppressing the Akt/mTOR Signaling Pathway In Vivo and In Vitro. Cells, 11(21), 3505. https://doi.org/10.3390/cells11213505

Chicago

Meiling Chen, Yihang Yu, Tao Mi, Qitong Guo, Bin Xiang, Xiaomao Tian, Liming Jin, et al. 2022. “MK-2206 Alleviates Renal Fibrosis by Suppressing the Akt/MTOR Signaling Pathway In Vivo and In Vitro.” Cells 11 (21): 3505. doi:10.3390/cells11213505.